» Articles » PMID: 23001125

Recurrent Somatic TET2 Mutations in Normal Elderly Individuals with Clonal Hematopoiesis

Abstract

Aging is characterized by clonal expansion of myeloid-biased hematopoietic stem cells and by increased risk of myeloid malignancies. Exome sequencing of three elderly females with clonal hematopoiesis, demonstrated by X-inactivation analysis, identified somatic TET2 mutations. Recurrence testing identified TET2 mutations in 10 out of 182 individuals with X-inactivation skewing. TET2 mutations were specific to individuals with clonal hematopoiesis without hematological malignancies and were associated with alterations in DNA methylation.

Citing Articles

Clonal hematopoiesis: elements associated with clonal expansion and diseases.

Ryu G, Koh Y, Jaiswal S, Yoon S Blood Res. 2025; 60(1):17.

PMID: 40080235 PMC: 11906933. DOI: 10.1007/s44313-025-00065-7.


Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study.

Iyama S, Chi S, Idogawa M, Ikezoe T, Fukushima K, Utsu Y Ann Hematol. 2025; 104(1):275-284.

PMID: 39921715 PMC: 11868205. DOI: 10.1007/s00277-025-06227-y.


Neomorphic leukemia-derived mutations in the TET2 enzyme induce genome instability via a substrate shift from 5-methylcytosine to thymine.

Jin G, Rong S, Yin D, Deng Z, Ding X, Sheng M Proc Natl Acad Sci U S A. 2025; 122(5):e2418318122.

PMID: 39874291 PMC: 11804724. DOI: 10.1073/pnas.2418318122.


Dynamic tracking of native precursors in adult mice.

Liu S, Adams S, Zheng H, Ehnot J, Jung S, Jeffrey G Elife. 2024; 13.

PMID: 39636670 PMC: 11620740. DOI: 10.7554/eLife.97504.


Impact of cytotoxic therapy on clonal hematopoiesis and myeloid neoplasms in breast cancer patients.

Kim H, Jin H, Kim J, Hong Y, Lee J Medicine (Baltimore). 2024; 103(46):e40540.

PMID: 39560556 PMC: 11575989. DOI: 10.1097/MD.0000000000040540.


References
1.
Gale R, Fielding A, Harrison C, Linch D . Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age. Br J Haematol. 1997; 98(3):512-9. DOI: 10.1046/j.1365-2141.1997.2573078.x. View

2.
Beerman I, Bhattacharya D, Zandi S, Sigvardsson M, Weissman I, Bryder D . Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A. 2010; 107(12):5465-70. PMC: 2851806. DOI: 10.1073/pnas.1000834107. View

3.
Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y . Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood. 1996; 88(1):59-65. View

4.
Busque L, Gilliland D . X-inactivation analysis in the 1990s: promise and potential problems. Leukemia. 1998; 12(2):128-35. DOI: 10.1038/sj.leu.2400936. View

5.
Ko M, Huang Y, Jankowska A, Pape U, Tahiliani M, Bandukwala H . Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature. 2010; 468(7325):839-43. PMC: 3003755. DOI: 10.1038/nature09586. View